BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38539413)

  • 1. Left Ventricular Longitudinal Strain Abnormalities in Childhood Exposure to Anthracycline Chemotherapy.
    Rique A; Cautela J; Thuny F; Michel G; Ovaert C; El Louali F
    Children (Basel); 2024 Mar; 11(3):. PubMed ID: 38539413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia.
    Christiansen JR; Massey R; Dalen H; Kanellopoulos A; Hamre H; Fosså SD; Ruud E; Kiserud CE; Aakhus S
    Am J Cardiol; 2016 Aug; 118(3):446-52. PubMed ID: 27296561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.
    Amedro P; Vincenti M; Abassi H; Lanot N; De La Villeon G; Guillaumont S; Gamon L; Mura T; Lopez-Perrin K; Haouy S; Sirvent A; Cazorla O; Vergely L; Lacampagne A; Avesani M; Sirvent N; Saumet L
    Int J Cardiol; 2022 May; 354():75-83. PubMed ID: 35167907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial function in children and young adult cancer survivors treated with anthracyclines.
    Patel NR; Chyu CK; Satou GM; Halnon NJ; Nguyen KL
    Echocardiography; 2018 Oct; 35(10):1649-1656. PubMed ID: 30053329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with Dexrazoxane-Anthracyclines association.
    Filomena D; Versacci P; Cimino S; Mattiucci C; Maestrini V; Cantisani D; Petronilli V; Agati L; Schiavetti A
    Int J Cardiol; 2020 Jan; 299():271-275. PubMed ID: 31422879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricle segmental function in childhood cancer survivors using speckle-tracking echocardiography.
    Akam-Venkata J; Kadiu G; Galas J; Lipshultz SE; Aggarwal S
    Cardiol Young; 2019 Dec; 29(12):1494-1500. PubMed ID: 31771663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal strain analysis for assessment of early cardiotoxicity during anthracycline treatment in childhood sarcoma: A single center experience.
    Alpman MS; Jarting A; Magnusson K; Manouras A; Henter JI; Broberg AM; Herold N
    Cancer Rep (Hoboken); 2023 Sep; 6(9):e1852. PubMed ID: 37354068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.
    Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I
    J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
    Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
    Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
    Slieker MG; Fackoury C; Slorach C; Hui W; Friedberg MK; Fan CS; Manlhiot C; Dillenburg R; Kantor P; Mital S; Liu P; Nathan PC; Mertens L
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e008869. PubMed ID: 31826678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.
    Song FY; Shi J; Guo Y; Zhang CJ; Xu YC; Zhang QL; Shu XH; Cheng LL
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):857-868. PubMed ID: 28255826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
    Charbonnel C; Convers-Domart R; Rigaudeau S; Taksin AL; Baron N; Lambert J; Ghez S; Georges JL; Farhat H; Lambert J; Rousselot P; Livarek B
    Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):392-401. PubMed ID: 28064155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
    Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
    Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
    Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
    ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Global Cardiac Function Using AutoSTRAIN Automatic Strain Quantitative Technology in Patients With Breast Cancer Undergoing Anthracycline-Based Chemotherapy.
    Gu J; Wang D; Jiang L; Huang Y; Ding L; Chen X; He Y; Zhou Z; Pu D
    Ultrasound Med Biol; 2023 Jan; 49(1):368-374. PubMed ID: 36283937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
    Kang Y; Xiao F; Chen H; Wang W; Shen L; Zhao H; Shen X; Chen F; He B
    Arq Bras Cardiol; 2018 Mar; 110(3):219-228. PubMed ID: 29694546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of persistent left ventricular regional wall motion abnormalities in childhood cancer survivors after anthracycline therapy: Assessment of global left ventricular myocardial performance by 3D speckle-tracking echocardiography.
    Okuma H; Noto N; Tanikawa S; Kanezawa K; Hirai M; Shimozawa K; Yagasaki H; Shichino H; Takahashi S
    J Cardiol; 2017 Oct; 70(4):396-401. PubMed ID: 28238564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.